© 2022 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
July 01, 2021
Dennis Bruemmer, MD discusses new agents and perspectives on care in treating patients with type 2 diabetes at high risk of CV, renal complications.
Investigators say that dietary habits in youth and young adult patients with diabetes can be impacted by income, employment, ethnicity, and a variety of other factors.
Elaine M. Apperson discusses treating diabetes in a pediatric population, including diabetes burnout, the effects of food deserts, and the consequences of COVID-19 on treatment.
June 30, 2021
Data show event rates varied two-fold across regions, with risk reduction of T2D and CKD events across geographic regions without heterogeneity.
Part 2 of a Q&A with Elena Christofides, MD highlighting important discussions surrounding ADA 2021, including semaglutide and obesity treatments as they relate to T2D.
Researchers push for transparency between health care professionals and patients with diabetes about the safety and efficacy of the influenza vaccine
June 29, 2021
In part 1 of a Q&A, Elena Christofides, MD highlights important discussions surrounding ADA 2021, including cardiometabolic medicine and risk factors for T1D.
Investigative ORMD-0701 has potential to regulate the insulin-glucagon balance in patients.
June 28, 2021
Changes in physical activity and diet may be main cause for worsening of diabetes control.
Data show similar family impact and distress scores at baseline and 3-months, highlighting continued impact of COVID-19 on T1D population.